In HCC, the anticancer effects of the lentivirus-mediated RNA interference (RNAi) targeting enhancer of zeste homolog 2 (EZH2), gambogic acid, and thyroid hormone are found through downregulation of STMN1 [21,22,23]. This evidence concerns the gene EZH2 and hepatocellular carcinoma.